S. Johnston

发表

From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response

P. Canoll, K. Swanson, A. Hawkins-Daarud, 2020, PLoS computational biology.

Improved model prediction of glioma growth utilizing tissue-specific boundary effects.

Paul Kinahan, K. Swanson, A. Hawkins-Daarud, 2019, Mathematical biosciences.

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma

Leland S. Hu, J. Sarkaria, R. Gatenby, 2019, American journal of clinical oncology.

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: a Multi-disciplinary Team-based, Multifactorial Analytical Approach

Leland S. Hu, J. Sarkaria, R. Gatenby, 2018, bioRxiv.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme

R. Gatenby, N. Raghunand, K. Swanson, 2019, Tomography.

Sex Differences in MRI-Based Metrics of Glioma Invasion and Brain Mechanics

Leland S. Hu, K. Swanson, A. Hawkins-Daarud, 2020, bioRxiv.

High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma.

M. Chamberlain, S. Johnston, 2010, Neuro-oncology.

Temozolomide for recurrent intracranial supratentorial platinum‐refractory ependymoma

M. Chamberlain, S. Johnston, 2009, Cancer.

Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series

M. Chamberlain, S. Johnston, 2011, Journal of Neuro-Oncology.

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients

Leland S. Hu, R. Gatenby, P. Canoll, 2019, BMC Cancer.

Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas

Kristin R. Swanson, Guy M. McKhann, Albert Lai, 2014, PloS one.

Measurement of the beam spin asymmetry of e→p→e′p′η in the deep-inelastic regime with CLAS

A. Alaoui, W. Brooks, H. Hakobyan, 2019, Physics Letters B.

Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology.

M. Chamberlain, S. Johnston, 2009, Cancer.

Neoplastic meningitis-related prognostic significance of the Karnofsky performance status.

M. Chamberlain, M. Glantz, S. Johnston, 2009, Archives of neurology.

Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma

Leland S. Hu, J. Sarkaria, K. Swanson, 2019, bioRxiv.

Natural Killer Cell Cytotoxicity: A Methods Analysis of Versus Flow Cytometry Chromium Release

Joyce M Tsuji, J. Scanlan, S. Motzer, 2003 .

Neoplastic meningitis

M. Chamberlain, S. Johnston, 2006, The Lancet. Neurology.

Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

David Basanta, Peter Canoll, Jacob Scott, 2014, Neuro-oncology.

Salvage therapy with single agent bevacizumab for recurrent glioblastoma

M. Chamberlain, S. Johnston, 2009, Journal of Neuro-Oncology.

Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival.

Leland S. Hu, Scott A. Whitmire, K. Swanson, 2018, JCO clinical cancer informatics.

From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment response

Alexander R. A. Anderson, Sandra K. Johnston, Kristin R. Swanson, 2019, bioRxiv.

Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab

M. Chamberlain, S. Johnston, 2011, Journal of Neuro-Oncology.

Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma

M. Chamberlain, S. Johnston, 2009, Journal of Neuro-Oncology.

Days gained response discriminates treatment response in patients with recurrent glioblastoma receiving bevacizumab-based therapies

Leland S. Hu, Scott A. Whitmire, K. Swanson, 2019, bioRxiv.

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

D. Silbergeld, D. Born, K. Swanson, 2014, The Journal of clinical investigation.

Bevacizumab for recurrent alkylator‐refractory anaplastic oligodendroglioma

M. Chamberlain, S. Johnston, 2009, Cancer.

Salvage therapy with single agent bendamustine for recurrent glioblastoma

M. Chamberlain, S. Johnston, 2011, Journal of Neuro-Oncology.

Deep neural network to locate and segment brain tumors outperformed the expert technicians who created the training data

Joseph Ross Mitchell, Konstantinos Kamnitsas, Leland S. Hu, 2020, Journal of medical imaging.

Letter: Surgical Decision Making From Image-Based Biophysical Modeling of Glioblastoma: Not Ready for Primetime.

P. Canoll, K. Swanson, J. Bruce, 2018, Neurosurgery.

Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C

M. Chamberlain, M. Glantz, S. Johnston, 2009, Journal of Neuro-Oncology.

Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry.

J. Scanlan, S. Motzer, V. Hertig, 2003, Biological research for nursing.

Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment With Standard-of-Care

Leland S. Hu, P. Canoll, K. Swanson, 2019, Frontiers in Oncology.

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas

A. Rademaker, J. Raizer, M. Mrugala, 2014, Journal of Neuro-Oncology.

Deep Learning Classification of Spinal Osteoporotic Compression Fractures on Radiographs using an Adaptation of the Genant Semiquantitative Criteria.

P. Cawthon, J. Jarvik, L. Lui, 2022, Academic radiology.

Sex Differences in Predictors of Seizure in Contrast-Enhancing Gliomas at Clinical Presentation: A Network Approach

Leland S. Hu, P. Canoll, K. Swanson, 2019, bioRxiv.

A phase II trial of PTK787/ZK 222584 (PTK787) in recurrent high-grade meningioma.

A. Rademaker, J. Raizer, M. Mrugala, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantifying Uncertainty and Robustness in a Biomathematical Model–Based Patient-Specific Response Metric for Glioblastoma

Sandra K. Johnston, Kristin R. Swanson, Andrea Hawkins-Daarud, 2019, JCO clinical cancer informatics.

Quantifying Uncertainty and Robustness in a Biomathematical Model Based Patient-Specific Response Metric for Glioblastoma

Sandra K. Johnston, Kristin R. Swanson, Andrea Hawkins-Daarud, 2018, bioRxiv.

Sex differences in seizure at presentation in glioma population

Leland S. Hu, K. Swanson, M. Mrugala, 2019, bioRxiv.

NEURO/MEDICAL ONCOLOGY

Scott N. Hwang, Katrina H. Smith, Susan M. Chang, 2013 .

A digital reference object for the 3D Hoffman brain phantom for characterization of PET neuroimaging quality

Mark Muzi, Sandra K. Johnston, Kristin R. Swanson, 2013, 2013 IEEE Nuclear Science Symposium and Medical Imaging Conference (2013 NSS/MIC).

Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas".

K. Swanson, A. Trister, A. Hawkins-Daarud, 2014, Neuro-oncology.

Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients

Leland S. Hu, R. Gatenby, P. Canoll, 2018, bioRxiv.

Recurrent spinal cord glioblastoma: salvage therapy with bevacizumab

M. Chamberlain, S. Johnston, 2011, Journal of Neuro-Oncology.

Sex-specific impact of patterns of imageable tumor growth on survival of primary patients

Gustavo De Leon, R. Gatenby, P. Canoll, 2018 .

Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.

D. Silbergeld, D. Born, K. Swanson, 2014, The Journal of clinical investigation.